| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/26/2005 | CN1568971A Angina pectoris treating composition |
| 01/26/2005 | CN1568964A Tanshinone II A sodium sulfonate powder injection preparation |
| 01/26/2005 | CN1568961A Dripping pills of verapamil hydrochloride and its preparation |
| 01/26/2005 | CN1568732A Tea capable of preventing and curing hypertension |
| 01/26/2005 | CN1186346C Thienopyrrolidinones |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186325C Tetrahydroisoquinoline derivative kind addition salt for treating cardiac and cerebral vascular diseases and its prepn |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/26/2005 | CN1186089C Dizziness treating Chinese medicine |
| 01/26/2005 | CN1186087C Chinese medical preparation for preventing and treating cardiovascular, cerebrovascular diseases and its preparation method |
| 01/26/2005 | CN1186074C Chinese patent drug for treating hemiplegia caused by apoplexy |
| 01/26/2005 | CN1186071C Medicine composition for treating chronic heart failure and its preparation |
| 01/26/2005 | CN1186069C Chinese medicine preparation for treating heart disease and its preparation method |
| 01/26/2005 | CN1186033C Health-care tea with blood fat, blood pressure and blood sugar reducing function and processing method thereof |
| 01/26/2005 | CN1186031C Chinese medicine decoction for curing apoplectic hemiparalysis |
| 01/26/2005 | CN1186026C Application of hydroxyethyl puerarin in preparation of new medicine for curing cerebrovascular diseases |
| 01/26/2005 | CN1186015C Traditional Chinese medicine compound oral sticking film for coronary heart disease and angina pectoris |
| 01/26/2005 | CN1186014C Multi-particulate pharmaceutical form with programmed and timed releasing and preparation method thereof |
| 01/26/2005 | CN1186013C Peroral medicine deliver controlled system providing temporal and spatial control |
| 01/25/2005 | US6846931 Organic acid salt of amlodipine |
| 01/25/2005 | US6846838 Ureido-substituted aniline compounds useful as serine protease inhibitors |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846822 Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension |
| 01/25/2005 | US6846815 Heterocyclic imines such as 2-anilino-6-quinoxalinol, used to suppress cell proliferation, differentiation, chemotaxis and/or activation; prophylaxis of restinosis; anticarcinogenic agents |
| 01/25/2005 | US6846672 Mitogenic oxygenase regulators |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/25/2005 | US6846485 Fish serine proteinase and their pharmaceutical and cosmetic use |
| 01/25/2005 | CA2354695C Compositions and methods for amelioration of human female sexual dysfunction |
| 01/25/2005 | CA2309352C Heterocyclic-substituted tricyclics as thrombin receptor antagonists |
| 01/25/2005 | CA2204769C Hemorrhoidal compositions and method of use |
| 01/20/2005 | WO2005005443A1 Organosilicon compounds and their use |
| 01/20/2005 | WO2005005442A1 Silicon compounds and their use |
| 01/20/2005 | WO2005004990A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | WO2005004914A1 MEDICINAL COMPOSITION CONTAINING NF-κB DECOY FOR TREATING AND PREVENTING RESPIRATORY DISEASES AND METHOD OF USING THE SAME |
| 01/20/2005 | WO2005004913A1 Pharmaceutical composition containing decoy and method of using the same |
| 01/20/2005 | WO2005004904A1 Method for treating diseases associated with modifications of qualitative and/ quantitative composition of blood extracellular dna (variants) |
| 01/20/2005 | WO2005004884A2 Use of nitrite salts for the treatment of cardiovascular conditions |
| 01/20/2005 | WO2005004789A2 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 01/20/2005 | WO2004098525A9 Uses of ion channel modulating compounds |
| 01/20/2005 | WO2004096802A9 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
| 01/20/2005 | WO2004091614A3 Stabilized amlodipine maleate formations |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2004038408A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 01/20/2005 | WO2003099762A8 Agents and methods for the treatment of disorders associated with oxidative stress |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | WO2003072114A8 Vascular therapeutics |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014841 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014831 Cancer, hypertension, obesity; diseases mediated by alteration of membrane structure and regulation of G-proteins or receptors |
| 01/20/2005 | US20050014819 Prenylflavonoids, chalcone derivatives, flavonols and/or glycosides; plant extracts; foods, beverages; insulin resistance |
| 01/20/2005 | US20050014817 Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014807 Therapeutic compounds for treating dyslipidemic conditions |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014803 Enzyme inhibitors |
| 01/20/2005 | US20050014800 Vision defects; anticancer agents; antitumor agents |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014783 Use of Rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014768 Antiinflammatory agents; analgesics |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014748 N-type calcium channel blockers |
| 01/20/2005 | US20050014747 Hypotensive agents; congestive heart failure |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | US20050014744 Benzothiazine and benzothiadiazine compounds |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014735 Therapy for autoimmune disease; antiallergens; antihistamines |
| 01/20/2005 | US20050014731 Treatment of Th1 dominated immunological disease states with non-endogenous gestagen compounds |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014699 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014683 Solvent extraction from plant |
| 01/20/2005 | US20050014675 Therapy for vascular system disease; using growth hormonr secretion promoter compound ; artheriosclerosis; cardiovascular disorders; anticholesterol agents |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones |
| 01/20/2005 | CA2569537A1 Use of betaine for treating arteritis |
| 01/20/2005 | CA2536827A1 Use of nitrite salts for the treatment of cardiovascular conditions |
| 01/20/2005 | CA2532833A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/20/2005 | CA2531512A1 Organosilicon compounds and their use |
| 01/20/2005 | CA2531511A1 Silicon compounds and their use |
| 01/20/2005 | CA2531283A1 Specific human antibodies |
| 01/19/2005 | EP1498491A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO Fc GAMMA RECEPTOR IIIa |
| 01/19/2005 | EP1498490A1 Process for producing antibody composition |
| 01/19/2005 | EP1498485A1 Cells with modified genome |
| 01/19/2005 | EP1498419A1 Process for preparing alkali metal salts of hydrophobic sulfonamides |